Table 2. Summary of results from sCNAphase on four cancer cell lines. The proportion of the genome that has undergone sCNA is calculated as the proportion of the genome with copy number not equal to nearest integer ploidy.
| Estimated ploidy | Proportion of genome | ||||
|---|---|---|---|---|---|
| Cell-line | Ploidy determined by sCNAphase | Ploidy determined by COSMIC | Undergone sCNA | Undergone LOH | Undergone LOH with more than two copies |
| HCC1143* Hypo-tetraploid | 3.7 | 3.36 | 83% | 46% | 30% |
| HCC1954* Tetraploid | 4.5 | 4.2 | 43% | 8% | 6% |
| HCC1187* Hypo-triploid | 2.7 | 2.64 | 28% | 58% | 8% |
| HCC2218# Tetraploid | 4.2 | 3.93 | 64% | 14% | 4% |